| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $503.9M | +3.2% |
| Cost of Revenue | $281.9M | +3.3% |
| Gross Profit | $222.0M | +3.0% |
| R&D Expense | $40.1M | +5.0% |
| SG&A Expense | $65.8M | -2.6% |
| Operating Income | $28.2M | +128.7% |
| Pre-tax Income | $28.0M | +128.6% |
| Income Tax | $10.7M | +92.2% |
| Net Income | $17.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.8M | +48.1% |
| Short-term Investments | $19.0M | -19.3% |
| Accounts Receivable | $72.8M | -4.4% |
| Inventory | $13.7M | +0.6% |
| Current Assets | $200.7M | +7.6% |
| Total Assets | $772.4M | -3.7% |
| Current Liabilities | $49.7M | -30.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $73.3M | +18.0% |
| Capital Expenditures | $28.1M | +29.7% |
| Investing Cash Flow | -$4.6M | +89.4% |
| Financing Cash Flow | -$41.9M | -49.9% |
| Free Cash Flow | $45.2M | +11.8% |
| +116.6% |
| EPS (Basic) | $0.66 | +117.5% |
| EPS (Diluted) | $0.66 | +117.5% |
| Total Liabilities |
| $77.1M |
| -26.3% |
| Stockholders' Equity | $695.3M | -0.3% |